Navigating Trump’s New Pharmaceutical Tariffs
New tariffs introduced by Donald Trump in April 2026 create significant legal and compliance challenges for pharmaceutical companies. The policy imposes tariffs of up to 100% on patented drugs and related ingredients under Section 232 of…